Upregulated type I collagen, fibronectin (FN1) and other ECM proteins in breast cancer (17,18) and upregulated collagens, non-collagen glycoproteins and proteoglycans in hepatocellular carcinoma (19) suggest that the expression and component changes in the ECM are crucial indicators of tumor progression. This evidence concerns the gene FN1 and neoplasm.